HER2/neu testing for anti-HER2-based therapies in patients with unresectable and/or metastatic gastric cancer | Journal of Clinical Pathology

Subscribe
Log In More

Log in via Institution
Log in via OpenAthens
Log in via ACP

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Citation Tools

Original articles

HER2/neu testing for anti-HER2-based therapies in patients with unresectable and/or metastatic gastric cancer

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:: Gómez-Martin C, Garralda E, Echarri MJ, et al

HER2/neu testing for anti-HER2-based therapies in patients with unresectable and/or metastatic gastric cancer

Journal of Clinical Pathology 2012;65:751-757.